MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,400,000 | +8.8% | 1,500,000 | -10.9% | 3.50% | +4.0% |
Q2 2023 | $43,570,073 | +7.7% | 1,684,193 | 0.0% | 3.37% | +26.2% |
Q1 2023 | $40,454,316 | +23.2% | 1,684,193 | 0.0% | 2.67% | +30.2% |
Q4 2022 | $32,841,764 | -7.2% | 1,684,193 | 0.0% | 2.05% | +21.5% |
Q3 2022 | $35,385,000 | -6.7% | 1,684,193 | -16.9% | 1.69% | -9.7% |
Q2 2022 | $37,931,000 | -21.7% | 2,027,324 | -7.8% | 1.87% | -26.9% |
Q1 2022 | $48,444,000 | +24.2% | 2,200,000 | -10.0% | 2.56% | +38.3% |
Q4 2021 | $39,000,000 | -19.9% | 2,445,147 | 0.0% | 1.85% | -26.7% |
Q3 2021 | $48,707,000 | +15.2% | 2,445,147 | 0.0% | 2.52% | +34.3% |
Q2 2021 | $42,277,000 | -12.8% | 2,445,147 | 0.0% | 1.88% | -6.3% |
Q1 2021 | $48,463,000 | +13.5% | 2,445,147 | 0.0% | 2.00% | +9.3% |
Q4 2020 | $42,692,000 | -9.4% | 2,445,147 | 0.0% | 1.83% | -21.8% |
Q3 2020 | $47,118,000 | -1.0% | 2,445,147 | 0.0% | 2.34% | -23.9% |
Q2 2020 | $47,583,000 | +39.0% | 2,445,147 | 0.0% | 3.07% | +34.4% |
Q1 2020 | $34,232,000 | -42.9% | 2,445,147 | 0.0% | 2.28% | -40.8% |
Q4 2019 | $59,955,000 | +143.7% | 2,445,147 | 0.0% | 3.86% | -8.4% |
Q3 2019 | $24,598,000 | – | 2,445,147 | – | 4.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |